DSS-induced colitis is exacerbated in STAT-6 knockout mice

Inflammatory Bowel Diseases

Volumn 11, Issue 10, 2005, Pages 883-889

  Elrod, John W ^a   Laroux, F Stephen ^a   Houghton, Jeffrey ^a   Carpenter, April ^a   Ando, Tomoaki ^a   Jennings, Merilyn H ^a   Grisham, Matt ^a   Walker, Nicole ^a   Alexander, J Steven ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Molecular and Cellular Physiology   (United States)

Author keywords

Inducible NO synthase; Inflammatory bowel disease; Interferon

Indexed keywords

DEXTRAN SULFATE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRATE; NITRITE; STAT6 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCENDING COLON; BLOOD LEVEL; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; GENE EXPRESSION REGULATION; INTESTINE CRYPT; INTESTINE INJURY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; SEVERITY OF ILLNESS INDEX; STAT6 TRANSCRIPTION FACTOR;

EID: 26444484949     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000182871.76434.57     Document Type: Article

References (33)

1. Grisham MB, Yamada T. Neutrophils, nitrogen oxides, and inflammatory, bowel disease. Ann N Y Acad Sci. 1992;664:103-115.
2. Agnello D, Lankford CS, Bream J, et al. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol. 2003;23:147-161.
3. Xia B, Crusius JB, Wu J, et al. Signal transducer and activator of transcription 6 gene G2964A polymorphism and inflammatory bowel disease. Clin Exp Immunol. 2003;131:446-450.
4. Heim MH. The Jak-STAT pathway: cytokine signaling from the receptor to the nucleus. J Recept Signal Transduct Res. 1999;19:75-120.
5. Takeda K, Kamanaka M, Tanaka T, et al. Impaired IL-13-mediated functions of macrophages in STAT-6-deficient mice. J Immunol. 1996;157:3220-3222.
6. de Jong DJ, Franke B, Naber AH, et al. No evidence for involvement of IL-4R and CD11B from the IBD1 region and STAT-6 in the IBD2 region in Crohn's disease. Eur J Hum Genet. 2003;11:884-887.
7. Klein W, Tromm A, Griga T, et al. Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Genes Immun. 2001;2:287-289.
8. Madden KB, Whitman L, Sullivan C, et al. Role of STAT-6 and mast cells in IL-4- and IL-13-induced alterations in murine intestinal epithelial cell function. J Immunol. 2002;169:4417-4422.
9. Okuda Y, Takahashi I, Kim JK, et al. Development of colitis in signal transducers and activators of transcription 6-deficient T-cell receptor alpha-deficient mice: a potential role of signal transducers and activators of transcription 6-independent interleukin-4 signaling for the generation of Th2-biased pathological CD4+ betabeta T cells. Am J Pathol. 2003;162:263-271.
10. Krieglstein CF, Cerwinka WH, Laroux FS, et al. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med. 2001;194:1207-1218.
11. Binion DG, Rafiee P, Ramanujam KS, et al. Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. Free Radic Biol Med. 2000;29:881-888.
12. Dikopoulos N, Nussler AK, Liptay S, et al. Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB-colitis. Eur J Clin Invest. 2001;31:234-239.
13. Yoshida Y, Iwai A, Itoh K, et al. Role of inducible nitric oxide synthase in dextran sulphate sodium-induced colitis. Aliment Pharmacol Ther. 2000;14(Suppl 1):26-32.
14. Sasaki M, Bharwani S, Jordan P, et al. Increased disease activity in eNOS-deficient mice in experimental colitis. Free Radic Biol Med. 2003;35:1679-1687.
15. Banan A, Fields JZ, Zhang Y, et al. iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol Gastrointest Liver Physiol. 2001;280:G1234-G1246.
16. Banan A, Farhadi A, Fields JZ, et al. The delta-isoform of protein kinase C causes inducible nitric-oxide synthase and nitric oxide upregulation: key mechanism for oxidant-induced carbonylation, nitration, and disassembly of the microtubule cytoskeleton and hyperpermeability of barrier of intestinal epithelia. J Pharmacol Exp Ther. 2003;305:482-494.
17. Banan A, Zhang LJ, Shaikh M, et al. Key role of PLC-gamma in EGF protection of epithelial barrier against iNOS upregulation and F-actin nitration and disassembly. Am J Physiol Cell Physiol. 2003;285:C977-C993.
18. Chen K, Hirota S, Wasa M, et al. Expression of NOS II and its role in experimental small bowel ulceration in rats. Surgery. 1999;126:553-561.
19. Coccia EM, Stellacci E, Marziali G, et al. IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation. Int Immunol. 2000;12:977-985.
20. Wei LH, Jacobs AT, Morris SM Jr, et al. IL-4 and IL-13 upregulate arginase 1 expression by cAMP and JAK/STAT-6 pathways in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2000;279:C248-C256.
21. Rutschman R, Lang R, Hesse M, et al. Cutting edge: STAT-6-dependent substrate depletion regulates nitric oxide production. J Immunol. 2001;166:2173-2177.
22. Hogaboam CM, Vallance BA, Kumar A, et al. Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J Clin Invest. 1997;100:2766-2776.
23. Kim HS, Berstad A. Experimental colitis in animal models. Scand J Gastroenterol. 1992;27:529-537.
24. Misko TP, Schilling RJ, Salvemini D, et al. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem. 1993;214:11-16.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C[T]) Method. Methods. 2001;25:402-408.
26. Dieleman LA, Pena AS, Meuwissen SG, et al. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1997;223:99-104.
27. Kankuri E, Vaali K, Knowles RG, et al. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-(3-[aminomethyl]benzyl)acetamidine. J Pharmacol Exp Ther. 2001;298:1128-1132.
28. Hall LR, Berger RB, Diaconu E, et al. Onchocerca volvulus keratitis (river blindness) is exacerbated in BALB/c IL-4 gene knockout mice. Cell Immunol. 2002;216:1-5.
29. Galijasevic S, Saed GM, Diamond MP, et al. Myeloperoxidase upregulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition. Proc Natl Acad Sci USA. 2003;100:14766-14771.
30. Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT-6-dependent mechanism. Gastroenterology. 2003;125:1419-1427.
31. Akimoto T, Numata F, Tamura M, et al. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J Exp Med. 1998;187:1537-1542.
32. Mathew A, MacLean JA, DeHaan E, et al. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med. 2001;193:1087-1096.
33. Oshima T, Laroux FS, Coe LL, et al. Interferongamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvasc Res. 2001;61:130-143.